The Elite Universal Test
Bank: AANP AGPCNP PSI
Final Exam Protocol v12.0
PART 0: Table of Contents
● PART I: The Preview
○ The Mission and Executive Overview
○ The "Critical Axioms" Cheat Sheet
● PART II: The Elite Test Bank
○ Tier 1 (Questions 1–10): Foundational Syntax & Application
■ Core Diagnostics, Baseline Guidelines, and Initial Interventions
○ Tier 2 (Questions 11–20): Complex Application & Simulation
■ Variable Shifts, Comorbid Confounds, and Secondary Management
○ Tier 3 (Questions 21–30): Grandmaster Synthesis
■ High-Stakes Multi-System Failures, Polypharmacy, and Advanced Triage
PART I: The Preview
The mastery of this document translates directly into board-certified, clinical supremacy by
replacing rote memorization with structural clinical reasoning. By systematically deconstructing
these thirty high-yield scenarios, the candidate will forge an impenetrable framework for
advanced primary care diagnostics, pharmacology, and gerontological management.
The "Critical Axioms" Cheat Sheet
● The Geriatric Glycemic Rule: Deprescribe and deintensify therapy in frail elders;
prioritizing the avoidance of hypoglycemia is clinically superior to maintaining tight A1C
control (e.g., targets of 7.1–8.5% are acceptable for severe frailty).
● The Ischemic Optic Nerve Protocol: Immediate administration of high-dose
corticosteroids is mandatory upon suspicion of Giant Cell Arteritis; the temporal artery
biopsy must follow, never precede, the initiation of steroids.
● The Asymptomatic Bacteriuria Law: Never screen or treat asymptomatic bacteriuria in
older adults, even in the presence of falls or delirium, unless localized genitourinary
symptoms or systemic infectious signs are present.
● The 2025 Cardiovascular Mandate: Stage 2 Hypertension (≥140/90 mmHg) demands
the immediate initiation of dual-combination pharmacotherapy alongside stringent lifestyle
modifications (e.g., <1500 mg sodium/day).
● The Oncologic Screening Threshold: Routine colorectal cancer screening strictly
, initiates at age 45 for average-risk adults; interventions for ages 76 to 85 must be highly
individualized based on comorbidity and prior screening history.
PART II: The Elite Test Bank
Tier 1: Foundational Syntax & Application
Q1: A 47-year-old male presents for a routine cardiovascular evaluation. Serial blood pressure
readings reveal a consistent pressure of 136/84 mmHg. The patient has no history of
cardiovascular disease and maintains a normal body mass index. Based on the 2025 American
Heart Association (AHA) guidelines for blood pressure management, which diagnostic
classification is the MOST ACCURATE? A) Elevated blood pressure B) Prehypertension C)
Stage 1 hypertension D) Stage 2 hypertension
● Answer: C (Stage 1 hypertension)
● Distractor Analysis:
○ A is incorrect: Elevated blood pressure is strictly defined by the AHA as a systolic
reading of 120-129 mmHg coupled with a diastolic reading of strictly less than 80
mmHg. The patient's diastolic reading of 84 mmHg excludes this classification.
○ B is incorrect: Prehypertension represents an outdated legacy classification from
the JNC-8 era. The 2025 AHA guidelines have completely abandoned this term in
favor of more aggressive early staging to combat long-term cardiovascular
remodeling.
○ D is incorrect: Stage 2 hypertension requires a systolic reading of 140 mmHg or
greater, or a diastolic reading of 90 mmHg or greater. The patient's pressures fall
below this critical threshold.
The Mentor's Analysis: The 2025 AHA guidelines unequivocally maintain that Stage 1
hypertension is defined by a systolic range of 130-139 mmHg or a diastolic range of 80-89
mmHg. When facing an initial diagnosis, the immediate priority is accurate staging to dictate the
timeline for non-pharmacologic or pharmacologic intervention. By utilizing Current AHA Criteria,
the clinician bypasses the common trap of relying on outdated diagnostic thresholds that delay
the implementation of lifestyle modifications.
AHA 2025 Blood Pressure Systolic (mmHg) Diastolic (mmHg)
Category
Normal < 120 < 80
Elevated 120 - 129 < 80
Stage 1 Hypertension 130 - 139 80 - 89
Stage 2 Hypertension ≥ 140 ≥ 90
Professional/Academic Intuition: Diagnostic precision drives the treatment cascade;
always apply the 130/80 mmHg threshold as the absolute baseline for Stage 1
hypertension.
Q2: A 72-year-old female presents with a new-onset, unilateral, throbbing headache,
accompanied by jaw pain during mastication and a low-grade fever. Erythrocyte sedimentation
rate (ESR) is elevated at 85 mm/hr. Based on the principles of rheumatologic emergency
management, which action is the FIRST priority? A) Schedule an immediate temporal artery
biopsy to confirm the diagnosis prior to treatment. B) Initiate high-dose systemic corticosteroids
immediately. C) Prescribe nonsteroidal anti-inflammatory drugs (NSAIDs) and reevaluate in 48
hours. D) Obtain a magnetic resonance imaging (MRI) scan of the brain to rule out an
, intracranial mass.
● Answer: B (Initiate high-dose systemic corticosteroids immediately.)
● Distractor Analysis:
○ A is incorrect: While a temporal artery biopsy remains the gold standard for
diagnostic confirmation, delaying pharmacological treatment to obtain surgical
histopathology places the patient at imminent risk for irreversible ischemic optic
neuropathy and permanent blindness.
○ C is incorrect: NSAIDs are profoundly inadequate for suppressing the severe,
granulomatous vascular inflammation seen in Giant Cell Arteritis and will fail entirely
to protect the optic nerve from ischemic infarction.
○ D is incorrect: While neuroimaging may be indicated for atypical presentations, the
classic presentation of temporal arteritis accompanied by jaw claudication
mandates immediate steroidal intervention over structural imaging, which would
needlessly delay life-altering therapy.
The Mentor's Analysis: Giant Cell Arteritis (GCA) constitutes an absolute medical emergency
due to the aggressive intimal hyperplasia that occludes the ophthalmic artery, precipitating
arteritic anterior ischemic optic neuropathy. When facing suspected GCA, the immediate priority
is the profound suppression of vascular inflammation. By utilizing High-Dose Glucocorticoids
preemptively, the clinician bypasses the common trap of waiting for histological confirmation
while the patient suffers irreversible visual loss. The pathological footprint of the disease persists
in the tissue for weeks, allowing ample time for subsequent surgical biopsy without
compromising diagnostic accuracy. Professional/Academic Intuition: Tissue is the issue,
but time is vision. Never withhold systemic corticosteroids while awaiting a temporal
artery biopsy in suspected Giant Cell Arteritis.
Q3: A 46-year-old asymptomatic male presents to the clinic requesting a general health check.
He has no personal or family history of gastrointestinal malignancies, inflammatory bowel
disease, or genetic polyposis syndromes. According to the United States Preventive Services
Task Force (USPSTF), which colorectal cancer screening recommendation is the MOST
APPROPRIATE? A) Defer screening until the patient reaches 50 years of age. B) Initiate
screening utilizing either a stool-based test or direct visualization test. C) Recommend a
diagnostic colonoscopy solely to establish a baseline. D) Obtain a carcinoembryonic antigen
(CEA) blood test.
● Answer: B (Initiate screening utilizing either a stool-based test or direct visualization test.)
● Distractor Analysis:
○ A is incorrect: The USPSTF explicitly updated its guidelines to lower the initiation
age for average-risk colorectal cancer screening from 50 to 45 years. This
modification was instituted to combat the statistically significant rise in early-onset
colorectal malignancies in younger demographics.
○ C is incorrect: While a colonoscopy serves as a primary screening modality, it is
classified as "screening" rather than "diagnostic" in an asymptomatic patient.
Furthermore, patients must be offered a comprehensive choice among highly
sensitive stool-based or visualization options rather than a singular mandate.
○ D is incorrect: Carcinoembryonic antigen (CEA) is a tumor marker utilized
exclusively for monitoring disease recurrence and treatment response in known
colorectal cancer patients, not as an initial screening tool for asymptomatic
individuals.
The Mentor's Analysis: The paradigm of oncologic prevention has shifted definitively to
address younger demographic vulnerabilities. The USPSTF assigns a Grade B
Bank: AANP AGPCNP PSI
Final Exam Protocol v12.0
PART 0: Table of Contents
● PART I: The Preview
○ The Mission and Executive Overview
○ The "Critical Axioms" Cheat Sheet
● PART II: The Elite Test Bank
○ Tier 1 (Questions 1–10): Foundational Syntax & Application
■ Core Diagnostics, Baseline Guidelines, and Initial Interventions
○ Tier 2 (Questions 11–20): Complex Application & Simulation
■ Variable Shifts, Comorbid Confounds, and Secondary Management
○ Tier 3 (Questions 21–30): Grandmaster Synthesis
■ High-Stakes Multi-System Failures, Polypharmacy, and Advanced Triage
PART I: The Preview
The mastery of this document translates directly into board-certified, clinical supremacy by
replacing rote memorization with structural clinical reasoning. By systematically deconstructing
these thirty high-yield scenarios, the candidate will forge an impenetrable framework for
advanced primary care diagnostics, pharmacology, and gerontological management.
The "Critical Axioms" Cheat Sheet
● The Geriatric Glycemic Rule: Deprescribe and deintensify therapy in frail elders;
prioritizing the avoidance of hypoglycemia is clinically superior to maintaining tight A1C
control (e.g., targets of 7.1–8.5% are acceptable for severe frailty).
● The Ischemic Optic Nerve Protocol: Immediate administration of high-dose
corticosteroids is mandatory upon suspicion of Giant Cell Arteritis; the temporal artery
biopsy must follow, never precede, the initiation of steroids.
● The Asymptomatic Bacteriuria Law: Never screen or treat asymptomatic bacteriuria in
older adults, even in the presence of falls or delirium, unless localized genitourinary
symptoms or systemic infectious signs are present.
● The 2025 Cardiovascular Mandate: Stage 2 Hypertension (≥140/90 mmHg) demands
the immediate initiation of dual-combination pharmacotherapy alongside stringent lifestyle
modifications (e.g., <1500 mg sodium/day).
● The Oncologic Screening Threshold: Routine colorectal cancer screening strictly
, initiates at age 45 for average-risk adults; interventions for ages 76 to 85 must be highly
individualized based on comorbidity and prior screening history.
PART II: The Elite Test Bank
Tier 1: Foundational Syntax & Application
Q1: A 47-year-old male presents for a routine cardiovascular evaluation. Serial blood pressure
readings reveal a consistent pressure of 136/84 mmHg. The patient has no history of
cardiovascular disease and maintains a normal body mass index. Based on the 2025 American
Heart Association (AHA) guidelines for blood pressure management, which diagnostic
classification is the MOST ACCURATE? A) Elevated blood pressure B) Prehypertension C)
Stage 1 hypertension D) Stage 2 hypertension
● Answer: C (Stage 1 hypertension)
● Distractor Analysis:
○ A is incorrect: Elevated blood pressure is strictly defined by the AHA as a systolic
reading of 120-129 mmHg coupled with a diastolic reading of strictly less than 80
mmHg. The patient's diastolic reading of 84 mmHg excludes this classification.
○ B is incorrect: Prehypertension represents an outdated legacy classification from
the JNC-8 era. The 2025 AHA guidelines have completely abandoned this term in
favor of more aggressive early staging to combat long-term cardiovascular
remodeling.
○ D is incorrect: Stage 2 hypertension requires a systolic reading of 140 mmHg or
greater, or a diastolic reading of 90 mmHg or greater. The patient's pressures fall
below this critical threshold.
The Mentor's Analysis: The 2025 AHA guidelines unequivocally maintain that Stage 1
hypertension is defined by a systolic range of 130-139 mmHg or a diastolic range of 80-89
mmHg. When facing an initial diagnosis, the immediate priority is accurate staging to dictate the
timeline for non-pharmacologic or pharmacologic intervention. By utilizing Current AHA Criteria,
the clinician bypasses the common trap of relying on outdated diagnostic thresholds that delay
the implementation of lifestyle modifications.
AHA 2025 Blood Pressure Systolic (mmHg) Diastolic (mmHg)
Category
Normal < 120 < 80
Elevated 120 - 129 < 80
Stage 1 Hypertension 130 - 139 80 - 89
Stage 2 Hypertension ≥ 140 ≥ 90
Professional/Academic Intuition: Diagnostic precision drives the treatment cascade;
always apply the 130/80 mmHg threshold as the absolute baseline for Stage 1
hypertension.
Q2: A 72-year-old female presents with a new-onset, unilateral, throbbing headache,
accompanied by jaw pain during mastication and a low-grade fever. Erythrocyte sedimentation
rate (ESR) is elevated at 85 mm/hr. Based on the principles of rheumatologic emergency
management, which action is the FIRST priority? A) Schedule an immediate temporal artery
biopsy to confirm the diagnosis prior to treatment. B) Initiate high-dose systemic corticosteroids
immediately. C) Prescribe nonsteroidal anti-inflammatory drugs (NSAIDs) and reevaluate in 48
hours. D) Obtain a magnetic resonance imaging (MRI) scan of the brain to rule out an
, intracranial mass.
● Answer: B (Initiate high-dose systemic corticosteroids immediately.)
● Distractor Analysis:
○ A is incorrect: While a temporal artery biopsy remains the gold standard for
diagnostic confirmation, delaying pharmacological treatment to obtain surgical
histopathology places the patient at imminent risk for irreversible ischemic optic
neuropathy and permanent blindness.
○ C is incorrect: NSAIDs are profoundly inadequate for suppressing the severe,
granulomatous vascular inflammation seen in Giant Cell Arteritis and will fail entirely
to protect the optic nerve from ischemic infarction.
○ D is incorrect: While neuroimaging may be indicated for atypical presentations, the
classic presentation of temporal arteritis accompanied by jaw claudication
mandates immediate steroidal intervention over structural imaging, which would
needlessly delay life-altering therapy.
The Mentor's Analysis: Giant Cell Arteritis (GCA) constitutes an absolute medical emergency
due to the aggressive intimal hyperplasia that occludes the ophthalmic artery, precipitating
arteritic anterior ischemic optic neuropathy. When facing suspected GCA, the immediate priority
is the profound suppression of vascular inflammation. By utilizing High-Dose Glucocorticoids
preemptively, the clinician bypasses the common trap of waiting for histological confirmation
while the patient suffers irreversible visual loss. The pathological footprint of the disease persists
in the tissue for weeks, allowing ample time for subsequent surgical biopsy without
compromising diagnostic accuracy. Professional/Academic Intuition: Tissue is the issue,
but time is vision. Never withhold systemic corticosteroids while awaiting a temporal
artery biopsy in suspected Giant Cell Arteritis.
Q3: A 46-year-old asymptomatic male presents to the clinic requesting a general health check.
He has no personal or family history of gastrointestinal malignancies, inflammatory bowel
disease, or genetic polyposis syndromes. According to the United States Preventive Services
Task Force (USPSTF), which colorectal cancer screening recommendation is the MOST
APPROPRIATE? A) Defer screening until the patient reaches 50 years of age. B) Initiate
screening utilizing either a stool-based test or direct visualization test. C) Recommend a
diagnostic colonoscopy solely to establish a baseline. D) Obtain a carcinoembryonic antigen
(CEA) blood test.
● Answer: B (Initiate screening utilizing either a stool-based test or direct visualization test.)
● Distractor Analysis:
○ A is incorrect: The USPSTF explicitly updated its guidelines to lower the initiation
age for average-risk colorectal cancer screening from 50 to 45 years. This
modification was instituted to combat the statistically significant rise in early-onset
colorectal malignancies in younger demographics.
○ C is incorrect: While a colonoscopy serves as a primary screening modality, it is
classified as "screening" rather than "diagnostic" in an asymptomatic patient.
Furthermore, patients must be offered a comprehensive choice among highly
sensitive stool-based or visualization options rather than a singular mandate.
○ D is incorrect: Carcinoembryonic antigen (CEA) is a tumor marker utilized
exclusively for monitoring disease recurrence and treatment response in known
colorectal cancer patients, not as an initial screening tool for asymptomatic
individuals.
The Mentor's Analysis: The paradigm of oncologic prevention has shifted definitively to
address younger demographic vulnerabilities. The USPSTF assigns a Grade B
